A class action complaint has been filed in U.S. District Court against Theranos over its blood testing process.
Theranos Class Action Background
The lawsuit was filed by Keller Rohrback LLP, and alleges that Theranos’ “tiny blood test” using its Edison technology “did not work.” Keller Rohrback argues that Theranos and Walgreens pharmacy “advertised that the Theranos test could conduct hundreds of blood tests with just a few drops of blood and produce fast results with the highest level of accuracy.”
Because Theranos’ tests “did not work, often required more than a finger prick of blood, and produced inaccurate results,” the law firm alleges that the company placed “tens of thousands of customers at risk for inaccurate medical diagnosis and/or testing.”
Law Firm: Theranos Didn’t Deliver
David Copley, a partner with Keller Rohrback, pointed out in a press release: “Theranos promised three simple things: a less invasive blood test, fast turnaround, and accurate results. The Theranos tests didn’t deliver on any of the three promises.”
The law firm is soliciting people to be involved in the class action who purchased Theranos lab or blood panel products directly from Theranos or from a Walgreens. They ask for those patients to call them or email the firm in order to be vetted to be a part of the class action lawsuit.
What Is A Class Action Lawsuit?
A Class Action lawsuit is a type of lawsuit where one of the parties in the legal proceedings are represented as a collective by one member of that group.
Supporters of class action lawsuits say that they are efficient because instead of multiple court cases and procedures, issues are decided with one case where the same exhibits and witnesses can be tapped in order to come to a verdict. Also, while one case may not be worth the financial cost, multiple cases could be worthy of a trial if they are put together.